Daniel Schindler

USPTO Granted Patents = 13 (Patent Applications = 17)

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 15 (Patent Applications = 14)

Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 205(Granted Patents)

Location History:

Newton, MA (US) (2015 - 2021)
Boston, MA (US) (2021)
Newton Upper Falls, MA (US) (2021 - 2023)

Company Filing History:

Ginkgo Bioworks, Inc.

patents

Years Active: 2015-2025

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12241057 - Methods for nucleic acid assembly and high throughput sequencing (2025-03-04),

2. 11845054 - Methods and devices for nucleic acids synthesis (2023-12-19),

3. 11702662 - Compositions and methods for high fidelity assembly of nucleic acids (2023-07-18),

4. 11130948 - Compositions and methods for multiplex nucleic acids synthesis (2021-09-28),

5. 11084014 - Methods and devices for nucleic acids synthesis (2021-08-10),

6. 11072789 - Methods for nucleic acid assembly and high throughput sequencing (2021-07-27),

7. 10927369 - Methods for sorting nucleic acids and multiplexed preparative in vitro cloning (2021-02-23),

8. 10273471 - Compositions and methods for multiplex nucleic acids synthesis (2019-04-30),

9. 10240194 - Methods for nucleotide sequencing and high fidelity polynucleotide synthesis (2019-03-26),

10. 10081807 - Methods for sorting nucleic acids and multiplexed preparative in vitro cloning (2018-09-25),

11. 9752176 - Methods for preparative in vitro cloning (2017-09-05),

12. 9295965 - Methods and devices for nucleic acid synthesis (2016-03-29),

13. 9187777 - Methods and devices for in situ nucleic acid synthesis (2015-11-17),

Title: The Innovative Contributions of Daniel Schindler

Introduction

Daniel Schindler is a prominent inventor based in Newton, MA, known for his significant contributions to the field of nucleic acid synthesis. With a total of 13 patents to his name, Schindler has made remarkable advancements in methods and apparatus related to high throughput sequencing and nucleic acid assembly. His work has implications for various applications in biotechnology and genetic research.

Latest Patents

Among his latest patents, Schindler has developed methods for nucleic acid assembly and high throughput sequencing. These methods and apparatus focus on the synthesis of high fidelity polynucleotides. Specifically, his inventions relate to the concurrent enzymatic removal of amplification sequences and the ligation of processed oligonucleotides into nucleic acid assemblies. One embodiment of his invention provides a method for producing a target nucleic acid with a predefined sequence, utilizing a plurality of oligonucleotides that include internal sequences identical to different portions of the target nucleic acid sequence. Additionally, he has created methods and devices for synthesizing polynucleotides with predefined sequences on a support, employing primer extension to generate overlapping construction oligonucleotides.

Career Highlights

Throughout his career, Schindler has worked with notable companies such as Gen9, Inc. and Ginkgo Bioworks, Inc. His innovative approaches have positioned him as a key figure in the biotechnology sector, contributing to advancements that enhance the efficiency and accuracy of nucleic acid synthesis.

Collaborations

Schindler has collaborated with esteemed colleagues, including Joseph M Jacobson and Li-yun A Kung. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Daniel Schindler's contributions to the field of nucleic acid synthesis exemplify the impact of innovation in biotechnology. His patents and collaborative efforts continue to shape the future of genetic research and applications.

This text is generated by artificial intelligence and may not be accurate.